| Autor: |
Cam M; ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France., Durieu E; ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France., Bodin M; ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France., Manousopoulou A; Faculty of Medicine, Cancer Sciences and Clinical and Experimental Medicine, University of Southampton, Southampton, UK., Koslowski S; ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France.; C.RIS Pharma, Parc Technopolitain, Atalante Saint Malo, Saint Malo, France., Vasylieva N; Department of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA., Barnych B; Department of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA., Hammock BD; Department of Entomology and Nematology and UCD Comprehensive Cancer Center, University of California, Davis, CA, USA., Bohl B; Institute of Reconstructive Neurobiology, University of Bonn, Bonn, Germany., Koch P; Institute of Reconstructive Neurobiology, University of Bonn, Bonn, Germany.; Central Institute of Mental Health, University of Heidelberg/ Medical, Faculty Mannheim and Hector Institut for Translational Brain Research (HITBR gGmbH), Mannheim, Germany., Omori C; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Department of Integrated Bioscience, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan., Yamamoto K; Department of Integrated Bioscience, Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan., Hata S; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan., Suzuki T; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan., Karg F; HPC INTERNATIONAL SAS and Atlantis Développement SAS, Noyal-Châtillon sur Seiche, Saint-Erblon, France., Gizzi P; Plate-forme TechMedILL, UMR 7242, ESBS - Pôle API, Illkirch cedex, France., Erakovic Haber V; Fidelta d.o.o., Zagreb, Croatia., Bencetic Mihaljevic V; Fidelta d.o.o., Zagreb, Croatia., Tavcar B; Fidelta d.o.o., Zagreb, Croatia., Portelius E; Clinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Pannee J; Clinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Blennow K; Clinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden., Zetterberg H; Clinical Neurochemical Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute, London, UK., Garbis SD; Faculty of Medicine, Cancer Sciences and Clinical and Experimental Medicine, University of Southampton, Southampton, UK., Auvray P; C.RIS Pharma, Parc Technopolitain, Atalante Saint Malo, Saint Malo, France., Gerber H; Foundation Eclosion, Switzerland.; Campus Biotech Innovation Park, Geneva, Switzerland.; Department of Biology, University of Fribourg, Fribourg, Switzerland., Fraering J; Foundation Eclosion, Switzerland.; Campus Biotech Innovation Park, Geneva, Switzerland., Fraering PC; Foundation Eclosion, Switzerland.; Campus Biotech Innovation Park, Geneva, Switzerland., Meijer L; ManRos Therapeutics, Centre de Perharidy, Roscoff, Bretagne, France. |
